Polyrizon Ltd. Receives Nasdaq Delisting Notice, Plans to Request Hearing to Stay Delisting

Reuters
2025/05/24
<a href="https://laohu8.com/S/PLRZ">Polyrizon Ltd.</a> Receives Nasdaq Delisting Notice, Plans to Request Hearing to Stay Delisting

Polyrizon Ltd., a biotech company specializing in intranasal hydrogels, has announced that it received a delisting notice from Nasdaq. The delisting is due to concerns over substantial shareholder dilution following the issuance of securities related to a purchase agreement dated March 31, 2025. Although the company's shares are not immediately affected, Polyrizon plans to request a hearing before a Nasdaq Hearings Panel to address the issue. This request will temporarily halt any suspension or delisting actions until the hearing and a subsequent decision by the Panel.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Polyrizon Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9457098-en) on May 23, 2025, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10